Sharp GW[au] - Search Results

Year	Number of Results
1954	1
1962	2
1963	2
1964	2
1965	2
1966	4
1968	8
1969	3
1970	4
1971	11
1972	7
1973	4
1974	6
1975	7
1976	7
1977	3
1978	9
1979	4
1980	9
1981	7
1982	4
1983	3
1984	7
1985	3
1986	6
1987	3
1988	4
1989	6
1990	3
1991	7
1992	1
1993	3
1994	3
1995	7
1996	7
1997	6
1998	7
1999	3
2000	4
2001	4
2002	7
2003	3
2004	5
2006	1
2007	4
2008	1
2010	3
2012	1
2013	2
2016	1
2021	0

1

Regulation of insulin release by calcium.

Wollheim CB, Sharp GW. Wollheim CB, et al. Among authors: sharp gw. Physiol Rev. 1981 Oct;61(4):914-73. doi: 10.1152/physrev.1981.61.4.914. Physiol Rev. 1981. PMID: 6117094 Review. No abstract available.

2

Mechanisms of inhibition of insulin release.

Sharp GW. Sharp GW. Am J Physiol. 1996 Dec;271(6 Pt 1):C1781-99. doi: 10.1152/ajpcell.1996.271.6.C1781. Am J Physiol. 1996. PMID: 8997178 Review.

3

Prostaglandin E1 inhibits endocytosis in the β-cell endocytosis.

Zhao Y, Fang Q, Straub SG, Lindau M, Sharp GW. Zhao Y, et al. Among authors: sharp gw. J Endocrinol. 2016 Jun;229(3):287-94. doi: 10.1530/JOE-15-0435. Epub 2016 Apr 11. J Endocrinol. 2016. PMID: 27068696

4

Evolving insights regarding mechanisms for the inhibition of insulin release by norepinephrine and heterotrimeric G proteins.

Straub SG, Sharp GW. Straub SG, et al. Among authors: sharp gw. Am J Physiol Cell Physiol. 2012 Jun 15;302(12):C1687-98. doi: 10.1152/ajpcell.00282.2011. Epub 2012 Apr 4. Am J Physiol Cell Physiol. 2012. PMID: 22492651 Free PMC article. Review.

5

Inhibition of insulin secretion: a fail-safe system.

McDermott AM, Sharp GW. McDermott AM, et al. Among authors: sharp gw. Cell Signal. 1993 May;5(3):229-34. doi: 10.1016/0898-6568(93)90014-d. Cell Signal. 1993. PMID: 7688543 Review.

6

Drug therapy for diarrheal diseases: a look ahead.

Donowitz M, Wicks J, Sharp GW. Donowitz M, et al. Among authors: sharp gw. Rev Infect Dis. 1986 May-Jun;8 Suppl 2:S188-201. doi: 10.1093/clinids/8.supplement_2.s188. Rev Infect Dis. 1986. PMID: 2873653 Review.

7

Glucose-stimulated signaling pathways in biphasic insulin secretion.

Straub SG, Sharp GW. Straub SG, et al. Among authors: sharp gw. Diabetes Metab Res Rev. 2002 Nov-Dec;18(6):451-63. doi: 10.1002/dmrr.329. Diabetes Metab Res Rev. 2002. PMID: 12469359 Review.

8

Triggering and augmentation mechanisms, granule pools, and biphasic insulin secretion.

Bratanova-Tochkova TK, Cheng H, Daniel S, Gunawardana S, Liu YJ, Mulvaney-Musa J, Schermerhorn T, Straub SG, Yajima H, Sharp GW. Bratanova-Tochkova TK, et al. Among authors: sharp gw. Diabetes. 2002 Feb;51 Suppl 1:S83-90. doi: 10.2337/diabetes.51.2007.s83. Diabetes. 2002. PMID: 11815463 Free article. Review.

9

Hypothesis: one rate-limiting step controls the magnitude of both phases of glucose-stimulated insulin secretion.

Straub SG, Sharp GW. Straub SG, et al. Among authors: sharp gw. Am J Physiol Cell Physiol. 2004 Sep;287(3):C565-71. doi: 10.1152/ajpcell.00079.2004. Am J Physiol Cell Physiol. 2004. PMID: 15308461 Free article. Review.

10

Action of cholera toxin on fluid and electrolyte movement in the small intestine.

Sharp GW. Sharp GW. Annu Rev Med. 1973;24:19-23. doi: 10.1146/annurev.me.24.020173.000315. Annu Rev Med. 1973. PMID: 4268017 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results